Soo Yu, Director at AIkido Pharma Inc. (AIKI), bought 4,500 shares at $3.69 ($17K) on 2022-12-14, disclosed to the SEC on 2022-12-16.
Open-market purchase of $17k AIKI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| DOMH | BUY | 2023-09-20 | $5K | — | Filing → |
| DOMH | BUY | 2023-08-28 | $6K | — | Filing → |
| DOMH | BUY | 2023-08-22 | $7K | — | Filing → |